Intestinal flora and fatty acid metabolism-related proteins

The term Intestinal flora and fatty acid metabolism-related proteins refers to a complex network of biological entities rather than a single therapeutic target. It encompasses the gut microbiota and the various host proteins—including enzymes like Fatty Acid Synthase (FASN), transporters like CD36, and receptors like GPR41 and GPR43—that mediate the metabolic crosstalk between intestinal bacteria and host lipid processing. This axis plays a critical role in energy harvesting, systemic inflammation, and the development of metabolic disorders such as obesity and insulin resistance. Because this term aggregates multiple distinct proteins and organisms, it is considered a biological pathway or research theme rather than a specific, druggable molecular target. Research in this area often focuses on how microbial metabolites, such as short-chain fatty acids, modulate host signaling pathways to influence health and disease outcomes.

Other names

Gut microbiota-fatty acid metabolism axisIntestinal microbiome and lipid metabolism proteins

This entry refers to a broad biological axis rather than a single drug target. Therapeutic interventions typically involve probiotics, prebiotics, or small molecules targeting specific receptors within this pathway, such as G protein-coupled receptors (GPR41/43) or peroxisome proliferator-activated receptors (PPARs).